Imaging dopamine transporters in Parkinson’s disease

Differentiating vascular parkinsonism from idiopathic Parkinson's disease: A systematic review

(2010) Seema Kalra et al.   MOVEMENT DISORDERS

Higher dopamine transporter density in Parkinson’s disease patients with depression

(2010) Andre C. Felicio et al.   PSYCHOPHARMACOLOGY

Diagnostic accuracy of 123I-FP-CIT SPECT in possible dementia with Lewy bodies

(2009) John T. O'Brien et al.   BRITISH JOURNAL OF PSYCHIATRY

Levodopa-Induced Dyskinesias in Parkinson Disease Are Independent of the Extent of Striatal Dopaminergic Denervation

(2009) Gurutz Linazasoro et al.   CLINICAL NEUROPHARMACOLOGY

Clinical and [123I]FP-CIT SPET imaging follow-up in patients with drug-induced parkinsonism

(2009) Michele Tinazzi et al.   JOURNAL OF NEUROLOGY

Olfaction in patients with suspected parkinsonism and scans without evidence of dopaminergic deficit (SWEDDs)

(2009) L Silveira-Moriyama et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Parkinson's disease is overdiagnosed clinically at baseline in diagnostically uncertain cases: A 3-year European multicenter study with repeat [123I]FP-CIT SPECT

(2009) Vicky L. Marshall et al.   MOVEMENT DISORDERS

Normal dopamine transporter single photon-emission CT scan in corticobasal degeneration

(2008) Sean S. O'Sullivan et al.   MOVEMENT DISORDERS

[123I]FP-CIT SPET imaging in drug-induced Parkinsonism

(2008) Michele Tinazzi et al.   MOVEMENT DISORDERS

PET demonstrates reduced dopamine transporter expression in PD with dyskinesias

(2008) A. R. Troiano et al.   NEUROLOGY

Technology Insight: imaging neurodegeneration in Parkinson's disease

(2008) David J Brooks   Nature clinical practice. Neurology